JackBarkinDO

PubMed

• 51 citations
  24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham.
  Daniel B. Rukstalis, Prem Rashid, William Bogache, Ronald F. Tutrone, Jack Barkin, Peter Chin, Henry H. Woo, Anthony L. Cantwell, Barrett E. Cowan, Damien M Bolton> ;BJU International. 2016 Oct 28
• Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy.
  MacDiarmid S, Al-Shukri S, Barkin J, Fianu-Jonasson A, Grise P, Herschorn S, Saleem T, Huang M, Siddiqui E, Stölzel M, Hemsted C, Nazir J, Hakimi Z, Drake MJ> ;J. Urol.. 2016-09-01
• Updates on radium-223 for castration-resistant prostate cancer presented at the Genitourinary Cancers Symposium, January 7-9, 2016, San Francisco, California.
  Jack Barkin> ;The Canadian Journal of Urology. 2016 Jun 1
• 2 citations
  The primary care physician's role in the monitoring and management of the potential sequelae of the medical treatment of prostate cancer: early and late.
  Victor Mak, Jack Barkin> ;The Canadian Journal of Urology. 2016 Feb 1
• 16 citations
  Testosterone deficiency syndrome: benefits, risks, and realities associated with testosterone replacement therapy.
  Jacob Hassan, Jack Barkin> ;The Canadian Journal of Urology. 2016 Feb 1
• 7 citations
  Nocturia: diagnosis and management for the primary care physicians
  Jack Barkin> ;The Canadian Journal of Urology. 2016 Feb 1
• The Changing Role of the Primary Care Physician in the Management of Urologic Conditions.
  Jack Barkin> ;The Canadian Journal of Urology. 2016 Feb 1
• 4 citations
  Optimizing subcutaneous injection of the gonadotropin-releasing hormone receptor antagonist degarelix.
  Jack Barkin, Shelley Burton, Carole Lambert> ;The Canadian Journal of Urology. 2016 Feb 1
• 30 citations
  Medical therapy for benign prostatic hyperplasia: a review.
  Van Asseldonk B, Barkin J, Elterman Ds> ;The Canadian Journal of Urology. 2015 Oct 1
• 8 citations
  Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
  Jack Barkin, Demitri Diles, Billy Franks, Todd Berner> ;The Canadian Journal of Urology. 2015 Aug 1
• 86 citations
  Three year results of the prostatic urethral L.I.F.T. study
  Claus G. Roehrborn, Daniel B. Rukstalis, Jack Barkin, Steven N. Gange, Neal D. Shore, Jonathan L. Giddens, Damien M Bolton, Barrett E. Cowan, Anthony L. Cantwell, Kevi...> ;The Canadian Journal of Urology. 2015 Jun 1
• PSA: The Little Kallikrein that 'COULD' and 'SHOULD'.
  Jack Barkin> ;The Canadian Journal of Urology. 2015 Jun 1
• 3 citations
  Risks, benefits, and approaches to hormonal blockade in prostate cancer. Highlights from the European Association of Urology Meeting, March 20-24, 2015, Madrid, Spain.
  Jack Barkin> ;The Canadian Journal of Urology. 2015 Jun 1
• How I do it: managing bone health in patients with prostate cancer.
  Jack Barkin> ;The Canadian Journal of Urology. 2014 Aug 1
• 1 citations
  A guide to the management of urologic dilemmas for the primary care physician (PCP).
  Jack Barkin, Matt T. Rosenberg, Martin Miner> ;The Canadian Journal of Urology. 2014 Jun 1
• 15 citations
  Testosterone deficiency: myth, facts, and controversy.
  Martin Miner, Jack Barkin, Matt T. Rosenberg> ;The Canadian Journal of Urology. 2014 Jun 1
• 7 citations
  Erectile dysfunction in primary care: a focus on cardiometabolic risk evaluation and stratification for future cardiovascular events.
  Martin Miner, Matt T. Rosenberg, Jack Barkin> ;The Canadian Journal of Urology. 2014 Jun 1
• 5 citations
  A practical primary care approach to lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH-LUTS).
  Matt T. Rosenberg, Erik S. Witt, Martin Miner, Jack Barkin> ;The Canadian Journal of Urology. 2014 Jun 1
• 12 citations
  A practical primary care approach to overactive bladder.
  Matt T. Rosenberg, Erik S. Witt, Jack Barkin, Martin Miner> ;The Canadian Journal of Urology. 2014 Jun 1
• "How we do it": the new guidebook in urology for primary care physicians.
  Jack Barkin> ;The Canadian Journal of Urology. 2014 Jun 1
• 66 citations
  Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
  Anthony L. Cantwell, William Bogache, Steven F. Richardson, Ronald F. Tutrone, Jack Barkin, James Fagelson, Peter Chin, Henry H. Woo> ;BJU International. 2014 Apr 1
• 34 citations
  Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in pat...
  Claus G. Roehrborn, Jack Barkin, Andrea Tubaro, Mark Emberton, Timothy Wilson, Betsy Brotherton, Ramiro Castro> ;BJU International. 2014 Apr 1
• 45 citations
  Prospective multi-center study elucidating patient experience after prostatic urethral lift.
  Neal D. Shore, Sheldon Freedman, Steven N. Gange, William G. Moseley, Sean Heron, Ron Tutrone, Thomas Brown, Jack Barkin> ;The Canadian Journal of Urology. 2014 Feb 1
• 3 citations
  Tolterodine for the treatment of urge urinary incontinence.
  Dean Elterman, Bilal Chughtai, Steven A. Kaplan, Jack Barkin> ;Expert Opinion on Pharmacotherapy. 2013 Sep 10
• 183 citations
  A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegr...
  Sender Herschorn, Jack Barkin, David Castro-Diaz, Jeffrey Frankel, Montserrat Espuña-Pons, Angelo Gousse, Matthias Stölzel, Nancy Martin, Adrie Gunther, Philip Van Ker...> ;Urology. 2013 Aug 1
• Join now to see all